These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8145177)

  • 1. Cognitive treatment for panic disorder.
    Gelder MG; Clark DM; Salkovskis P
    J Psychiatr Res; 1993; 27 Suppl 1():171-8. PubMed ID: 8145177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discussion of "methodological controversies in the treatment of panic disorder".
    Klein DF
    Behav Res Ther; 1996; 34(11-12):849-53; discussion 855-63. PubMed ID: 8990537
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E; Rickels K; Weiss S; Zavodnick S
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB; Hayward C; King R; Ehlers A; Margraf J; Maddock R; Clark D; Roth WT; Agras WS
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growing placebo response rate: the problem in recent therapeutic trials?
    Uhlenhuth EH; Matuzas W; Warner TD; Thompson PM
    Psychopharmacol Bull; 1997; 33(1):31-9. PubMed ID: 9133749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three years follow-up of panic disorder patients: a naturalistic study.
    Rosenberg NK; Rosenberg R
    Scand J Psychol; 1994 Sep; 35(3):254-62. PubMed ID: 7939487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay sensitivity, failed clinical trials, and the conduct of science.
    Otto MW; Nierenberg AA
    Psychother Psychosom; 2002; 71(5):241-3. PubMed ID: 12207103
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical recovery from panic disorder is associated with evidence of changes in cardiovascular regulation.
    Middleton HC; Ashby M
    Acta Psychiatr Scand; 1995 Feb; 91(2):108-13. PubMed ID: 7778467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    Başoğlu M; Marks IM; Kiliç C; Swinson RP; Noshirvani H; Kuch K; O'Sullivan G
    Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary evidence for cognitive mediation during cognitive-behavioral therapy of panic disorder.
    Hofmann SG; Meuret AE; Rosenfield D; Suvak MK; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Consult Clin Psychol; 2007 Jun; 75(3):374-9. PubMed ID: 17563154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
    Sheikh JI; Swales PJ
    Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coincidence of schizophrenia and panic disorder].
    Rupprecht R; Ströhle A
    Nervenarzt; 1999 Mar; 70(3):265-8. PubMed ID: 10231815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive bias in panic disorder patients and changes after cognitive-behavioral treatments.
    Westling BE; Ost LG
    Behav Res Ther; 1995 Jun; 33(5):585-8. PubMed ID: 7598682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sequence of improvement of the symptoms encountered in patients with panic disorder.
    Rifkin A
    Compr Psychiatry; 1991; 32(6):559-60. PubMed ID: 1778083
    [No Abstract]   [Full Text] [Related]  

  • 17. Panic disorder: long-term pharmacotherapy and discontinuation.
    Rickels K; Schweizer E
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive behavior therapy for treatment-refractory panic disorder.
    Pollack MH; Otto MW; Kaspi SP; Hammerness PG; Rosenbaum JF
    J Clin Psychiatry; 1994 May; 55(5):200-5. PubMed ID: 8071270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-life-onset panic disorder: clinical and demographic characteristics of a patient sample.
    Hassan R; Pollard CA
    J Geriatr Psychiatry Neurol; 1994; 7(2):84-8. PubMed ID: 8204193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up study of patients with panic disorder.
    Judd FK; Burrows GD; Norman TR
    Arch Gen Psychiatry; 1991 Sep; 48(9):860-2. PubMed ID: 1929779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.